Print（PDF/102KB） Mar. 01, 2016 Corporate
Sumitomo Dainippon Pharma announces Organizational Realignment and Changes Related to Officers and Other Key Positions
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that it will accelerate further improvement of management efficiency and pursue vitalization of business structure and sustained growth in performance by making the following organizational realignment and changes related to its officers and other key positions, effective April 1, 2016:
I. Organizational Realignment (effective April 1, 2016)
Corporate Departments
- Corporate Governance is created.*1
- Corporate Communications is dissolved as a department. *1
- General Affairs is dissolved as a department. *1
- Global R&D Office is dissolved and its functions are transferred to Global Corporate Planning.*2
- External Affairs is renamed (in Japanese language only).
- Career Development is dissolved and its functions are transferred to Personnel.
- Procurement is dissolved and its functions are transferred to Corporate Service Center and Manufacturing Management.
- *1 We are committed to continuously pursuing the establishment of a highly effective corporate governance system, aiming for fuller realization of our Corporate Mission and Management Mission. We seek to strengthen our corporate governance system by integrating the corporate governance-related functions of Global Corporate Planning and of Legal Affairs with the functions of Corporate Communications and of General Affairs. In this connection, the functions of General Affairs related to environment and safety are transferred to Corporate Service Center.
- *2 We seek to enhance the efficiency and strategic planning by transferring the functions relating to overall management of global R&D to Global Corporate Planning.
Sales & Marketing (Division)
- Sub-divisions Higashi-Nippon Region and Nishi-Nippon Region are both dissolved and all the Region Management (Departments) under these sub-divisions are dissolved.*3
- Tokyo Branch is created by integrating Tokyo Branch I and Tokyo Branch II.
- Tokai Branch is created by integrating Shizuoka Branch and Nagoya Branch.
- Keiji-Hokuriku Branch is created by integrating Hokuriku Branch and Keiji Branch.
- Osaka Branch is created by integrating Osaka Branch I and Osaka Branch II.
- Kyushu Branch is created by integrating Kyushu-kita Branch and Kyushu-minami Branch.
- *3 The region-based sub-division structure is terminated in a constructive posture and the strategy planning and other functions of the Region Management (Departments) are transferred to the respective branches, with a view to empowering the branches and strengthening the local market-focused approach in the sales and marketing activities through measures tailored to the local needs.
II. Changes related to Directors and Executive Officers
(1) Promotions (effective April 1, 2016)
Member, Board of Directors, Executive Vice President
- Hiroshi Nomura (currently Member, Board of Directors, Senior Executive Officer)
Senior Executive Officer
- Yoshiharu Ikeda (currently Executive Officer)
- Hitoshi Odagiri (currently Executive Officer)
- Kazuo Koshiya (currently Executive Officer)
(2) New appointment (effective April 1, 2016)
Executive Officer
- Hideyuki Harada (currently Director, Research Planning & Intelligence)
(3) Retiring Executive Officers (effective March 31, 2016)
- Makoto Hara (currently Member, Board of Directors, Executive Vice President)
- Yoshihiro Okada (currently Member, Board of Directors, Senior Executive Officer)
- Susumu Nakajima (currently Senior Executive Officer)
| Post as of April 1, 2016 | Current post | Name |
|---|---|---|
| Representative Director, Senior Executive Vice President Drug Research; Drug Development; Technology Research & Development; Regenerative & Cellular Medicine; Global Oncology |
Representative Director, Senior Executive Vice President Executive Director, Drug Research (Division); Global R&D Office; Global Oncology Office |
Hiroshi Noguchi |
| Member, Board of Directors, Executive Vice President External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Drug Development (Division); Special Assignments |
Member, Board of Directors, Senior Executive Officer Global Corporate Planning; Global Business Development; External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Regenerative & Cellular Medicine Office; Drug Development (Division) |
Hiroshi Nomura |
| Member, Board of Directors, Senior Executive Officer Corporate Governance; Personnel |
Member, Board of Directors, Senior Executive Officer Corporate Communications; Personnel; General Affairs; Procurement; Corporate Service Center |
Masaru Ishidahara |
| Senior Executive Officer Executive Director, Manufacturing (Division); Technology Research & Development (Division) |
Executive Officer Executive Director, Technology Research & Development (Division); Corporate IT Management |
Yoshiharu Ikeda |
| Senior Executive Officer Executive Director, Sales & Marketing (Division) |
Executive Officer Director, Personnel; Career Development |
Hitoshi Odagiri |
| Senior Executive Officer Boston Biomedical Pharma, Inc.; Global Oncology Office; Oncology Clinical Development Unit; Oncology Strategy Unit; Head of Global Oncology Office |
Executive Officer Boston Biomedical Pharma, Inc.; Head of Global Oncology Office |
Kazuo Koshiya |
| Executive Officer Global Business Development; Legal Affairs; Intellectual Property; Corporate IT Management; International Business Management; Head of Global Business Development for Sumitomo Dainippon Pharma Group |
Executive Officer Sunovion Pharmaceuticals Inc.; Director, Global Business Development; Head of Global Business Development for Sumitomo Dainippon Pharma Group |
Hiroyuki Baba |
| Executive Officer Director, Global Corporate Planning; Regenerative & Cellular Medicine Office |
Executive Officer Director, Regenerative & Cellular Medicine Office |
Toru Kimura |
| Executive Officer Director, Corporate Governance; Corporate Service Center |
Executive Officer Director, Global Corporate Planning |
Hajime Kinuta |
| Executive Officer Executive Director, Drug Research (Division) |
Director, Research Planning & Intelligence | Hideyuki Harada |
III. Changes in Personnel (effective April 1, 2016)
| Position as of April 1, 2016 | Current position | Name |
|---|---|---|
| Senior Strategic Officer | Global Corporate Planning | Ryoichi Urushihara |
| Senior Business Development Officer | Group I, Global Business Development | Katsumi Tanaka |
| Senior Governance Officer | Director, Legal Affairs | Noriaki Okuda |
| Senior Communication Officer | Director, International Business Management | Atsuko Higuchi |
| Senior Employee Development Officer | Director, Career Development | Toru Nakatsuka |
| Cancer Institute Senior Fellow | Group Manager, Discovery Chemistry & Technology II, DSP Cancer Institute | Hitoshi Ban |
| Senior Oncology Business Officer | - | Tsutomu Nakagawa |
| Director, Global Business Development | Deputy Executive Director, Drug Research (Division) Director, External Innovation Development Office |
Shigeyuki Nishinaka |
| External Affairs; Corporate Secretariat & Industry Affairs Deputy Executive Director, Sales & Marketing (Division) |
External Affairs; Corporate Secretariat & Industry Affairs Deputy Executive Director, Sales & Marketing (Division) |
Shinjiro Takayama |
| Director, External Affairs | Director, External Affairs | Kenichi Mochizuki |
| Director, Legal Affairs | Group Manager, Contract Management Group, Legal Affairs | Tetsuya Uyama |
| Director, Internal Auditing | Director, Internal Auditing; Deputy Corporate Service Center | Takashi Kutsunai |
| Director, Corporate Secretariat & Industry Affairs | Corporate Secretariat & Industry Affairs | Fumihiro Nishi |
| Director, Personnel | Director, Personnel Development | Ichiro Takahashi |
| Director, International Business Management | Director, Region Management, Nishi-Nippon Region | Kenji Toba |
| Director, Regenerative & Cellular Medicine Office | Group Manager, Group II, Global Business Development | Atsushi Tsuchida |
| Position as of April 1, 2016 | Current position | Name |
|---|---|---|
| Senior Postmarketing Officer | Director, Corporate Communications | Akiko Watanabe |
| Position as of April 1, 2016 | Current position | Name |
|---|---|---|
| Senior Research Fellow, Applied Drug Creation Research | Senior Advisor, Drug Research (Division) | Hiroyuki Nakahira |
| Senior Research Fellow, Innovative Drug Creation Research | Senior Specialist, Isobe Lab., Innovative Drug Discovery Laboratories | Yoshiaki Isobe |
| Senior Research Fellow, iPS Cell-Based Drug Discovery | Group Manager, iPS Cell-Based Drug Discovery Group, Innovative Drug Discovery Laboratories | Atsushi Ikeda |
| Senior Research Fellow, Higher brain function Research | Senior Specialist, Ikeda Lab., Drug Development Research Laboratories | Kazuhito Ikeda |
| Senior Research Fellow, Molecular Pathophysiology Research | Group Manager, Assay Development Group, Genomic Science Laboratories | Hidetaka Nagata |
| Senior Research Fellow, In silico Drug Discovery | Group Manager, In silico Drug Discovery Technology Group, Genomic Science Laboratories | Kazuto Yamazaki |
| Director, Research Planning & Intelligence | Group Manager, Planning Group, Global Corporate Planning | Setsuko Yamamoto |
| Director, Research Administration | Deputy Director, Preclinical Research Laboratories | Masashi Yabuki |
| Director, External Innovation Development Office | External Innovation Development Office | Masakazu Hashimoto |
| Director, Drug Development Research Laboratories | Director, Drug Development Research Laboratories Director, Preclinical Research Laboratories |
Isao Shimizu |
| Director, Preclinical Research Laboratories | Group Manager, Research Planning Group, Research Planning & Intelligence | Kiyoko Bando |
| Position as of April 1, 2016 | Current position | Name |
|---|---|---|
| Senior Medical Fellow | Senior Advisor (Principal), Drug Development (Division) | Hiroshi Aino |
| Director, Medical Affairs | Group Manager, Specialty Medical Affairs Group, Medical Affairs | Takeshi Nishimura |
| Position as of April 1, 2016 | Current position | Name |
|---|---|---|
| Executive Director, Technology Research & Development (Division) | Director, Technology Research & Development Management | Kazuya Otoda |
| Senior Research Fellow, CMC based Drug Development | Group Manager, Solid Dosage Form Research Group, Formulation Research & Development Laboratories | Yasushi Ochiai |
| Director, Technology Research & Development Management | Director, Process Chemistry Research & Development Laboratories | Kazuhiko Takahashi |
| Director, Process Chemistry Research & Development Laboratories | Group Manager, Project Planning & Management Group, Technology Research & Development Management | Mikio Sasaki |
| Director, Formulation Research & Development Laboratories | Group Manager, Planning & Administration Group, Technology Research & Development Management | Kimihiro Mizuno |
| Position as of April 1, 2016 | Current position | Name |
|---|---|---|
| Deputy Executive Director, Sales & Marketing (Division) | Senior Director, Nishi-Nippon Region | Mitsuyuki Taniguchi |
| Director, Personnel Development | Group Manager, Career Development Group, Personnel Development | Junya Kanto |
| Director, Sapporo Branch | Director, Sapporo Branch, Higashi-Nippon Region | Jiro Imura |
| Director, Tohoku Branch | Director, Saitama Branch, Higashi-Nippon Region | Masahiro Hamakubo |
| Director, Kita-Kanto Branch | Director, Kita-Kanto Branch, Higashi-Nippon Region | Osamu Yasunaga |
| Director, Koshinetsu Branch | Group Manager, Kochi Group, Shikoku Branch, Nishi-Nippon Region | Yoshito Yamashita |
| Director, Chiba Branch | Director, Tokyo Branch II, Higashi-Nippon Region | Tsuneharu Inoue |
| Director, Saitama Branch | Director, Osaka Branch II, Nishi-Nippon Region | Haruo Kusakabe |
| Director, Tokyo Branch | Director, Tohoku Branch, Higashi-Nippon Region | Motohide Takahara |
| Senior Manager, Hospital Promotion, Tokyo Branch | Group Manager, Product Group I, Product Management & Promotion Planning | Takafumi Shimizu |
| Director, Yokohama Branch | Director, Yokohama Branch, Higashi-Nippon Region | Koji Yamazaki |
| Director, Tokai Branch | Director, Nagoya Branch, Nishi-Nippon Region | Shunichi Saito |
| Senior Manager, Hospital Promotion, Tokai Branch | Group Manager, Tokyo Group III, Tokyo Branch I, Higashi-Nippon Region | Yasutoshi Araki |
| Director, Keiji-Hokuriku Branch | Director, Keiji Branch, Nishi-Nippon Region | Masao Akiyama |
| Director, Osaka Branch | Director, Osaka Branch I, Nishi-Nippon Region | Masaichi Fujimoto |
| Senior Manager, Hospital Promotion, Osaka Branch | Group Manager, Planning & Marketing Group, Sales & Marketing Management | Takayuki Sato |
| Director, Kobe Branch | Group Manager, Strategy Group, Region Management, Nishi-Nippon Region | Masayuki Mukai |
| Director, Chugoku Branch | Director, Chugoku Branch, Nishi-Nippon Region | Hisayuki Ichikawa |
| Director, Shikoku Branch | Group Manager, Wholesaler Service Group, Tohoku Branch, Higashi-Nippon Region | Yasushi Miyauchi |
| Director, Kyushu Branch | Director, Region Management, Higashi-Nippon Region | Tomomasa Ueno |
| Senior Manager, Hospital Promotion, Kyushu Branch | Group Manager, Miyazaki Group, Kyushu-minami Branch, Nishi-Nippon Region | Hiroshi Takaoka |
| Position as of April 1, 2016 | Current position | Name |
|---|---|---|
| Deputy Executive Director, Manufacturing (Division) Director, Suzuka Plant |
Director, Suzuka Plant | Hotaka Hashimoto |
| Director, Manufacturing Management | Director, Manufacturing Management Director, Procurement |
Kenji Ueno |
| Director, Ibaraki Plant | Director, Ibaraki Plant Senior Manager, Manufacturing, Ibaraki Plant |
Hiroyuki Nishii |
| Senior Manager, Manufacturing, Ibaraki Plant | Section Manager, Manufacturing, Suzuka Plant | Kazuyuki Fujihara |
Inquiries from the Press